Ichikawa T - Search Results

1

Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices.

Ono Y, Tamiya T, Ichikawa T, Kunishio K, Matsumoto K, Furuta T, Ohmoto T, Ueki K, Louis DN. Ono Y, et al. Among authors: ichikawa t. J Neuropathol Exp Neurol. 1996 Oct;55(10):1026-31. J Neuropathol Exp Neurol. 1996. PMID: 8857999

2

Accumulation of wild-type p53 in astrocytomas is associated with increased p21 expression.

Ono Y, Tamiya T, Ichikawa T, Matsumoto K, Furuta T, Ohmoto T, Akiyama K, Seki S, Ueki K, Louis DN. Ono Y, et al. Among authors: ichikawa t. Acta Neuropathol. 1997 Jul;94(1):21-7. doi: 10.1007/s004010050667. Acta Neuropathol. 1997. PMID: 9224526

3

[Brainstem glioma with supratentorial meningeal dissemination--a case report].

Ichikawa T, Matsumoto K, Chikama M, Ohmoto T. Ichikawa T, et al. No To Shinkei. 1992 Oct;44(10):941-6. No To Shinkei. 1992. PMID: 1285996 Japanese.

4

[Gene transduction for experimental brain tumors using recombinant adenovirus vector].

Ichikawa T, Tamiya T, Adachi Y, Ono Y, Matsumoto K, Furuta T, Ohmoto T, Yoshida Y, Hamada H. Ichikawa T, et al. No To Shinkei. 1998 Aug;50(8):731-8. No To Shinkei. 1998. PMID: 9757466 Japanese.

5

Primary brain tumors in children under age 3 years.

Furuta T, Tabuchi A, Adachi Y, Mizumatsu S, Tamesa N, Ichikawa T, Tamiya T, Matsumoto K, Ohmoto T. Furuta T, et al. Among authors: ichikawa t. Brain Tumor Pathol. 1998;15(1):7-12. doi: 10.1007/BF02482094. Brain Tumor Pathol. 1998. PMID: 9879457

6

Experimental gene therapy for brain tumors using adenovirus-mediated transfer of cytosine deaminase gene and uracil phosphoribosyltransferase gene with 5-fluorocytosine.

Adachi Y, Tamiya T, Ichikawa T, Terada K, Ono Y, Matsumoto K, Furuta T, Hamada H, Ohmoto T. Adachi Y, et al. Among authors: ichikawa t. Hum Gene Ther. 2000 Jan 1;11(1):77-89. doi: 10.1089/10430340050016175. Hum Gene Ther. 2000. PMID: 10646641

7

In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus.

Ichikawa T, Tamiya T, Adachi Y, Ono Y, Matsumoto K, Furuta T, Yoshida Y, Hamada H, Ohmoto T. Ichikawa T, et al. Cancer Gene Ther. 2000 Jan;7(1):74-82. doi: 10.1038/sj.cgt.7700086. Cancer Gene Ther. 2000. PMID: 10678359

8

[Herpes simplex type-1 virus-based vectors for gene therapy].

Ichikawa T, Saeki Y, Tamiya T, Chiocca EA, Ohmoto T. Ichikawa T, et al. Nihon Rinsho. 2000 Apr;58(4):822-7. Nihon Rinsho. 2000. PMID: 10774201 Review. Japanese.

9

Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant.

Ikeda K, Wakimoto H, Ichikawa T, Jhung S, Hochberg FH, Louis DN, Chiocca EA. Ikeda K, et al. Among authors: ichikawa t. J Virol. 2000 May;74(10):4765-75. doi: 10.1128/jvi.74.10.4765-4775.2000. J Virol. 2000. PMID: 10775615 Free PMC article.

10

Bone marrow engraftment in a rodent model of chemical carcinogenesis but no role in the histogenesis of hepatocellular carcinoma.

Ishikawa H, Nakao K, Matsumoto K, Nishimura D, Ichikawa T, Hamasaki K, Eguchi K. Ishikawa H, et al. Among authors: ichikawa t. Gut. 2004 Jun;53(6):884-9. doi: 10.1136/gut.2003.026047. Gut. 2004. PMID: 15138218 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,695 results

Search Page

Filters